1-12 of 12
Dana M. Brantley-Sieders
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 262: Statistical Bliss: A novel framework for statistical assessment of drug synergy

Richard E. Grewelle, Kalin L. Wilson, Dana M. Brantley-Sieders
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 262.
https://doi.org/10.1158/1538-7445.AM2021-262
Published: 01 July 2021
View article titled, Abstract 262: Statistical Bliss: A novel framework for statistical assessment of drug synergy
Journal Articles

Abstract 4139: Investigations of drug synergy reveal promising efficacy of EphA2 inhibition combined with CDK inhibition in triple-negative breast cancer

Kalin L. Wilson, Dana M. Brantley-Sieders
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4139.
https://doi.org/10.1158/1538-7445.AM2020-4139
Published: 15 August 2020
View article titled, Abstract 4139: Investigations of drug synergy reveal promising efficacy of EphA2 inhibition combined with CDK inhibition in triple-negative breast cancer
Journal Articles

Abstract 5017: EphA2 is a clinically relevant target for breast cancer bone metastatic disease

Dana M. Brantley-Sieders
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 5017.
https://doi.org/10.1158/1538-7445.AM2020-5017
Published: 15 August 2020
View article titled, Abstract 5017: EphA2 is a clinically relevant target for breast cancer bone metastatic disease
Journal Articles

Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival

Thomas A. Werfel, Shan Wang, Meredith A. Jackson, Taylor E. Kavanaugh, Meghan Morrison Joly, Linus H. Lee, Donna J. Hicks, Violeta Sanchez, Paula Gonzalez Ericsson, Kameron V. Kilchrist, Somtochukwu C. Dimobi, Samantha M. Sarett, Dana M. Brantley-Sieders, Rebecca S. Cook, Craig L. Duvall
Journal: Cancer Research
Cancer Res (2018) 78 (7): 1845–1858.
https://doi.org/10.1158/0008-5472.CAN-17-2388
Published: 01 April 2018
View article titled, Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival
Open the PDF for Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival in another window
Includes: Supplementary data
Journal Articles

The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer

Victoria M. Youngblood, Laura C. Kim, Deanna N. Edwards, Yoonha Hwang, Pranav R. Santapuram, Steven M. Stirdivant, Pengcheng Lu, Fei Ye, Dana M. Brantley-Sieders, Jin Chen
Journal: Cancer Research
Cancer Res (2016) 76 (7): 1825–1836.
https://doi.org/10.1158/0008-5472.CAN-15-0847
Published: 31 March 2016
View article titled, The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer
Open the PDF for The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer in another window
Journal Articles

Abstract 4198: mTORC2 directs breast morphogenesis through Rictor-dependent PKCα/Rac1 signaling independent of Akt

Dana M. Brantley-Sieders, Meghan M. Morrison, Donna J. Hicks, Rebecca S. Cook
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4198.
https://doi.org/10.1158/1538-7445.AM2015-4198
Published: 01 August 2015
View article titled, Abstract 4198: mTORC2 directs breast morphogenesis through Rictor-dependent PKCα/Rac1 signaling independent of Akt
Journal Articles

Abstract 970: Mass spectrometry analysis of PIK3CA mutant mammary epithelial cells identifies EGFR as a paracrine effector of PI3K in basal-like breast cancer

Christian D. Young, Lisa J. Zimmerman, Michael L. Gatza, Meghan M. Morrison, Corbin A. Whitwell, Neil E. Bhola, Ariella B. Hanker, Thomas Stricker, Premal Patel, Dana M. Brantley-Sieders, Charles M. Perou, Ben H. Park, Daniel C. Liebler, Rebecca S. Cook, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 970.
https://doi.org/10.1158/1538-7445.AM2014-970
Published: 01 October 2014
View article titled, Abstract 970: Mass spectrometry analysis of PIK3CA mutant mammary epithelial cells identifies EGFR as a paracrine effector of PI3K in basal-like breast cancer
Journal Articles

Angiocrine Factors Modulate Tumor Proliferation and Motility through EphA2 Repression of Slit2 Tumor Suppressor Function in Endothelium

Dana M. Brantley-Sieders, Charlene M. Dunaway, Meghana Rao, Sarah Short, Yoonha Hwang, Yandong Gao, Deyu Li, Aixiang Jiang, Yu Shyr, Jane Y. Wu, Jin Chen
Journal: Cancer Research
Cancer Res (2011) 71 (3): 976–987.
https://doi.org/10.1158/0008-5472.CAN-10-3396
Published: 01 February 2011
View article titled, Angiocrine Factors Modulate Tumor Proliferation and Motility through EphA2 Repression of Slit2 Tumor Suppressor Function in Endothelium
Open the PDF for Angiocrine Factors Modulate Tumor Proliferation and Motility through EphA2 Repression of Slit2 Tumor Suppressor Function in Endothelium in another window
Includes: Supplementary data
Journal Articles

Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy

Guanglei Zhuang, Dana M. Brantley-Sieders, David Vaught, Jian Yu, Lu Xie, Sam Wells, Dowdy Jackson, Rebecca Muraoka-Cook, Carlos Arteaga, Jin Chen
Journal: Cancer Research
Cancer Res (2010) 70 (1): 299–308.
https://doi.org/10.1158/0008-5472.CAN-09-1845
Published: 04 January 2010
View article titled, Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
Open the PDF for Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy in another window
Includes: Supplementary data
Journal Articles

Low Levels of Tumor Necrosis Factor α Increase Tumor Growth by Inducing an Endothelial Phenotype of Monocytes Recruited to the Tumor Site

Bin Li, Alicia Vincent, Justin Cates, Dana M. Brantley-Sieders, D. Brent Polk, Pampee P. Young
Journal: Cancer Research
Cancer Res (2009) 69 (1): 338–348.
https://doi.org/10.1158/0008-5472.CAN-08-1565
Published: 31 December 2008
View article titled, Low Levels of Tumor Necrosis Factor α Increase Tumor Growth by Inducing an Endothelial Phenotype of Monocytes Recruited to the Tumor Site
Open the PDF for Low Levels of Tumor Necrosis Factor α Increase Tumor Growth by Inducing an Endothelial Phenotype of Monocytes Recruited to the Tumor Site in another window
Includes: Supplementary data
Journal Articles

Ephrin-A1 Facilitates Mammary Tumor Metastasis through an Angiogenesis-Dependent Mechanism Mediated by EphA Receptor and Vascular Endothelial Growth Factor in Mice

Dana M. Brantley-Sieders, Wei Bin Fang, Yoonha Hwang, Donna Hicks, Jin Chen
Journal: Cancer Research
Cancer Res (2006) 66 (21): 10315–10324.
https://doi.org/10.1158/0008-5472.CAN-06-1560
Published: 01 November 2006
View article titled, Ephrin-A1 Facilitates Mammary Tumor Metastasis through an Angiogenesis-Dependent Mechanism Mediated by EphA Receptor and Vascular Endothelial Growth Factor in Mice
Open the PDF for Ephrin-A1 Facilitates Mammary Tumor Metastasis through an Angiogenesis-Dependent Mechanism Mediated by EphA Receptor and Vascular Endothelial Growth Factor in Mice in another window
Journal Articles

Ephrin-A1 induces tumor cell migration via a Rho GTPase and Jak kinase-dependent pathway

Monica A. Parker, Dana M. Brantley-Sieders, Wei B. Fang, Jin Chen
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1290.
Published: 01 May 2005
View article titled, Ephrin-A1 induces tumor cell migration via a Rho GTPase and Jak kinase-dependent pathway